Research and Markets: Global Thyroid Cancer Pipeline Update 2014
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9l2wjq/thyroid_cancer) has announced the addition of the "Thyroid cancer Pipeline Highlights - 2014 Update" report to their offering.
“Thyroid cancer Pipeline Highlights - 2014 Update”
The latest report Thyroid cancer Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Thyroid cancer market. It covers emerging therapies for Thyroid cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
- The report provides Thyroid cancer pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
- The report provides Thyroid cancer pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
- The report provides Thyroid cancer pipeline molecules by the Originator Company.
Short-term Launch Highlights:
- Find out which Thyroid cancer pipeline products will be launched in the US and Ex-US till 2017.
- Thyroid cancer phase 3 clinical trial pipeline molecules
- Thyroid cancer phase 2 clinical trial pipeline molecules
- Thyroid cancer phase 1 clinical trial pipeline molecules
- Thyroid cancer preclinical research pipeline molecules
- Thyroid cancer discovery stage pipeline molecules
- Thyroid cancer pipeline molecules short-term launch highlights
For more information visit http://www.researchandmarkets.com/research/9l2wjq/thyroid_cancer